Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HCV Infection

NCT02021656 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

384

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic HCV Infection

Interventions

DRUG: LDV/SOF

Sponsor

Gilead Sciences